Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomized Placebo-Controlled Double-Blind Study of the Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

NCT01559922 is registered in ClinicalTrials.gov with Suneva Medical, Inc. as lead sponsor.

NCT NCT01559922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01559922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomized Placebo-Controlled Double-Blind Study of the Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction
Lead sponsor
Suneva Medical, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2012
Completion date
February 28, 2014
Enrollment
175 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic acne scar